
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
With great power comes great vulnerability: an ethical analysis of psychedelics’ therapeutic mechanisms proposed by the REBUS hypothesis
Daniel Villiger, Manuel Trachsel
Journal of Medical Ethics (2023) Vol. 49, Iss. 12, pp. 826-832
Open Access | Times Cited: 16
Daniel Villiger, Manuel Trachsel
Journal of Medical Ethics (2023) Vol. 49, Iss. 12, pp. 826-832
Open Access | Times Cited: 16
Showing 16 citing articles:
Distinctive But Not Exceptional: The Risks of Psychedelic Ethical Exceptionalism
Katherine Cheung, Brian D. Earp, Kyle Patch, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 16-28
Closed Access | Times Cited: 14
Katherine Cheung, Brian D. Earp, Kyle Patch, et al.
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 16-28
Closed Access | Times Cited: 14
Giving Consent to the Ineffable
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Daniel Villiger
Neuroethics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 10
Psychedelic-assisted psychotherapy: where is the psychotherapy research?
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 9
Jacob S. Aday, David Horton, Gisele Fernandes‐Osterhold, et al.
Psychopharmacology (2024) Vol. 241, Iss. 8, pp. 1517-1526
Closed Access | Times Cited: 9
Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences
Eirini K. Argyri, Jules Evans, David Luke, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 7
Eirini K. Argyri, Jules Evans, David Luke, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 7
Same Same but Different: On Psychedelic Exceptionalism
Daniel Villiger
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 92-95
Open Access
Daniel Villiger
The American Journal of Bioethics (2025) Vol. 25, Iss. 1, pp. 92-95
Open Access
Mental disorder and its treatment as a transformative experience
Daniel Villiger
Phenomenology and the Cognitive Sciences (2025)
Open Access
Daniel Villiger
Phenomenology and the Cognitive Sciences (2025)
Open Access
Mitigating Ethical Issues in Training for Psychedelic Therapy
Christopher Poppe, Daniel Villiger, Dimitris Repantis, et al.
Neuroethics (2025) Vol. 18, Iss. 1
Open Access
Christopher Poppe, Daniel Villiger, Dimitris Repantis, et al.
Neuroethics (2025) Vol. 18, Iss. 1
Open Access
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 8
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 8
History, Hype, and Responsible Psychedelic Medicine: A Qualitative Study of Psychedelic Researchers
Michaela Barber, John Gardner, Adrian Carter
Journal of Bioethical Inquiry (2024)
Open Access | Times Cited: 1
Michaela Barber, John Gardner, Adrian Carter
Journal of Bioethical Inquiry (2024)
Open Access | Times Cited: 1
Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis
Nadav Liam Modlin, Tyler McPhee, Nira Zazon, et al.
Psychedelic Medicine (2024)
Closed Access | Times Cited: 1
Nadav Liam Modlin, Tyler McPhee, Nira Zazon, et al.
Psychedelic Medicine (2024)
Closed Access | Times Cited: 1
How to Make Psychedelic-Assisted Therapy Safer
Daniel Villiger
Cambridge Quarterly of Healthcare Ethics (2024), pp. 1-15
Open Access | Times Cited: 1
Daniel Villiger
Cambridge Quarterly of Healthcare Ethics (2024), pp. 1-15
Open Access | Times Cited: 1
Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions
Nadav Liam Modlin, Michael Creed, Maria Sarang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 109-135
Open Access | Times Cited: 1
Nadav Liam Modlin, Michael Creed, Maria Sarang, et al.
Neuropsychiatric Disease and Treatment (2024) Vol. Volume 20, pp. 109-135
Open Access | Times Cited: 1
What do health professionals think about implementing psilocybin-assisted therapy in palliative care for existential distress? A World Café qualitative study
Marianne Masse-Grenier, Sue-Ling Chang, Ariane Bélanger, et al.
Palliative & Supportive Care (2024), pp. 1-11
Open Access | Times Cited: 1
Marianne Masse-Grenier, Sue-Ling Chang, Ariane Bélanger, et al.
Palliative & Supportive Care (2024), pp. 1-11
Open Access | Times Cited: 1
Psychedelic-assisted psychotherapy: Where is the psychotherapy research?
Jacob S. Aday, David P Horton, Gisele Fernandes‐Osterhold, et al.
(2023)
Open Access | Times Cited: 3
Jacob S. Aday, David P Horton, Gisele Fernandes‐Osterhold, et al.
(2023)
Open Access | Times Cited: 3
Ethical Aspects of Psychedelic-Assisted Treatments: An Overview
Christopher Poppe, Dimitris Repantis
Current topics in behavioral neurosciences (2024)
Closed Access
Christopher Poppe, Dimitris Repantis
Current topics in behavioral neurosciences (2024)
Closed Access
Guruism and Cultic Social Dynamics in Psychedelic Practices and Organisations
Jules Evans, Joel C. Adams
Current topics in behavioral neurosciences (2024)
Closed Access
Jules Evans, Joel C. Adams
Current topics in behavioral neurosciences (2024)
Closed Access
Considerations in the Application of Psychedelic-Augmented Psychotherapy: A Commentary on Clinical Mechanisms
Alexander De Foe
Psychoactives (2023) Vol. 2, Iss. 2, pp. 162-173
Open Access
Alexander De Foe
Psychoactives (2023) Vol. 2, Iss. 2, pp. 162-173
Open Access